Louse-borne relapsing fever (LBRF) is a vector-borne infection characterized by the spirochaete Borrelia recurrentis, a restricted human infection spread by the body louse Pediculus humanus humanus. A person dies in 10% to 40% of cases when adequate therapy is unavailable and in 2% to 5% of treated patients. In addition, antibiotic treatment may cause a possibly lethal Jarisch-Herxheimer response.
Furthermore, severe epidemics of louse-borne relapsing fever have formerly arisen in Africa and Eurasia, although the illness is now predominantly prevalent in northern Africa. The primary treatment of louse-borne relapsing fever is based on preventing body lice infection. Infections of this kind are associated with inadequate personal cleanliness, overpopulation, and low socioeconomic level.